Search hospitals > New Jersey > Hackensack
Hackensack University Medical Center
Claim this profileHackensack, New Jersey 07601
Global Leader in Cancer
Global Leader in Lymphoma
Conducts research for Leukemia
Conducts research for Multiple Myeloma
Conducts research for Solid Tumors
982 reported clinical trials
52 medical researchers
Summary
Hackensack University Medical Center is a medical facility located in Hackensack, New Jersey. This center is recognized for care of Cancer, Lymphoma, Leukemia, Multiple Myeloma, Solid Tumors and other specialties. Hackensack University Medical Center is involved with conducting 982 clinical trials across 1,003 conditions. There are 52 research doctors associated with this hospital, such as Martin E Gutierrez, Katharine Offer, Burton E. Appel, and Derek Hanson, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lymphoma
Global LeaderStage IV
Stage III
Stage II
Top PIs
Martin E GutierrezJohn Theurer Cancer Center at Hackensack University Medical Center3 years of reported clinical research
Expert in Lung Cancer
Expert in Solid Tumors
48 reported clinical trials
85 drugs studied
Katharine OfferHackensack University Medical Center8 years of reported clinical research
Expert in Brain Tumor
Expert in Neuroblastoma
35 reported clinical trials
67 drugs studied
Burton E. AppelHackensack University Medical Center6 years of reported clinical research
Studies Burkitt Lymphoma
Studies Hodgkin's Lymphoma
23 reported clinical trials
60 drugs studied
Derek Hanson, MDHackensack University Medical Center3 years of reported clinical research
Studies Brain Tumor
Studies Brain Cancer
17 reported clinical trials
38 drugs studied
Clinical Trials running at Hackensack University Medical Center
Prostate Cancer
Cancer
Kidney Cancer
Breast Cancer
Lymphoma
Bladder Cancer
Testicular cancer
Multiple Myeloma
Neuroblastoma
Lung Cancer
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
PF-06821497
for Small Cell Lung Cancer
This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.
Recruiting1 award Phase 15 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Hackensack University Medical Center?
Hackensack University Medical Center is a medical facility located in Hackensack, New Jersey. This center is recognized for care of Cancer, Lymphoma, Leukemia, Multiple Myeloma, Solid Tumors and other specialties. Hackensack University Medical Center is involved with conducting 982 clinical trials across 1,003 conditions. There are 52 research doctors associated with this hospital, such as Martin E Gutierrez, Katharine Offer, Burton E. Appel, and Derek Hanson, MD.
Where is Hackensack University Medical Center located?
To reach Hackensack University Medical Center, located at 30 Prospect Avenue, Hackensack, New Jersey: Take I-80 West to NJ-17 South towards Paramus. Use the right two lanes to exit at 17A-17B for NJ-4 East towards Hackensack. Continue on NJ-4 East, then take the Prospect Avenue exit towards the hospital, which will be on your left.
Who should I call to ask about financial aid or insurance network?
For financial assistance, insurance, and billing inquiries at Hackensack University Medical Center, please call 888-568-3522. To request a copy of the Financial Assistance Policy and Application by mail, contact the Patient Financial Services department at (201) 383-1043. This policy covers all emergency and medically necessary services, including employed physician services and behavioral health.
What insurance does Hackensack University Medical Center accept?
Hackensack University Medical Center accepts a wide range of insurance plans, including but not limited to Aetna, Amerigroup, AmeriHealth, Cigna, Clover, Horizon BCBS, and United HC. The hospital is also part of various networks such as Aetna HMO/PPO, Amerihealth PPO/HMO, Cigna HMO/PPO, Horizon HMO/POS/EPO, and United Healthcare Choice Plus/PPO. Patients are advised to verify their eligibility and coverage directly with their insurance provider, as insurance agreements may change.
What awards or recognition has Hackensack University Medical Center received?
Hackensack University Medical Center, located in Hackensack, New Jersey, has been awarded nearly $1 million in grants by the New Jersey Health Foundation to support research in areas such as cancer, infectious disease, community health, education, diabetes, and rheumatology. It stands out as the only hospital in New Jersey to have both its adult and children's hospitals ranked #1, according to U.S. News & World Report, 2023-24. Furthermore, it is nationally-ranked in six specialties.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.